This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and other innovations. This award falls under that SBIR opportunity which was set aside for total small business participation. Qoolabs will perform the work in San Diego from September 2022 through September 2024 to conduct research and development projects focused on monoclonal antibodies for immune targets in swine, advancing the NIH's and NIAID's goals in infectious disease prevention and treatment.
Generated 12/29/23, 3:42 PM